Antipsychotics for the management of agitation in adults with personality disorders or cognitive impairment: a review of the clinical effectiveness and guidelines
CADTH
Record ID 32014000090
English
Authors' recommendations:
Limited evidence suggested that there may be some improvement with respect to aggression, anger or impulsivity in treating borderline personality disorder patients with antipsychotics. However, results need to be interpreted with caution as the studies were generally small in size and of short duration. One guideline did not recommend antipsychotics for the medium- or long- term treatment of borderline personality disorder. One guideline mentioned that psychotropic agents may improve affective symptoms and impulsivity in borderline personality disorder but cautioned that there is no strong evidence base.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
http://www.cadth.ca/media/pdf/htis/sep-2013/RC0476-Antipsychotic-Final.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Psychomotor Agitation
- Schizophrenia
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.